Are analogue insulins better than soluble in continuous subcutaneous insulin infusion? Results of a meta-analysis.
about
Short acting insulin analogues versus regular human insulin in patients with diabetes mellitusShort acting insulin analogues versus regular human insulin in patients with diabetes mellitusShort-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitusTherapeutics of diabetes mellitus: focus on insulin analogues and insulin pumps.The Relative Effectiveness of Pumps Over MDI and Structured Education (REPOSE): study protocol for a cluster randomised controlled trialTreatment of transient neonatal diabetes mellitus: insulin pump or insulin glargine? Our experience.Insulin analogs for the treatment of diabetes mellitus: therapeutic applications of protein engineering.New strategies in insulin treatment: analogues and noninvasive routes of administration.Design of non-standard insulin analogs for the treatment of diabetes mellitusPlasma insulin profiles after subcutaneous injection: how close can we get to physiology in people with diabetes?Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics.Evolution of diabetes insulin delivery devicesTreatment options for paediatric diabetes.Improved glycemic control with intraperitoneal versus subcutaneous insulin in type 1 diabetes: a randomized controlled trial.Special management of insulin lispro in continuous subcutaneous insulin infusion in young diabetic children: a randomized cross-over study.Patient management of long-term continuous subcutaneous insulin infusion.A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countries.Neonatal diabetes mellitus: Insulin pump as an alternative management strategy.
P2860
Q24246142-D1DB5381-15B4-42B7-A135-80F26BFC9221Q24246326-C4A111F9-1D05-4ADC-A595-27F263803C91Q26471380-A5C470E6-F3E5-44CA-85EA-526C319738E9Q33879565-EB0C9CB7-C001-4B35-B501-028825CEFE68Q34151785-0A9BE31B-2EB4-4FDB-B49F-7E51D1E00684Q34563147-62A621AC-7043-449A-BD8D-0E36BD245B7BQ35988978-A5E86DD8-D946-4F85-A7F5-DF5383D88DD0Q36089348-4997E005-CAB2-4BE6-9E0B-A0068C461CDAQ36374363-0CC34979-1CDE-428A-A1BC-7358C1961C60Q36554243-70DAB4B7-7D22-4C44-A50E-47F969A0D588Q37275651-3241FBD8-2B68-430B-BC97-5BE4F8928045Q37761746-06D92FB4-52B8-4426-A843-462994F4BDCFQ37776269-49BF0A34-D048-4474-AC37-AE568F8EDF0DQ42117491-60F9C876-3943-40C1-BF53-C597A67AD641Q45137203-CB2456D1-144D-4340-830F-86C40F715544Q48484527-A575E17B-F3CA-46C9-94C1-922EDE5FF4BFQ51294558-E1D1783A-EAD7-48CD-A9B5-838659008066Q51358543-0A518CCA-CA23-4767-90C2-4ED6F51AE8D3
P2860
Are analogue insulins better than soluble in continuous subcutaneous insulin infusion? Results of a meta-analysis.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Are analogue insulins better t ...... n? Results of a meta-analysis.
@ast
Are analogue insulins better t ...... n? Results of a meta-analysis.
@en
type
label
Are analogue insulins better t ...... n? Results of a meta-analysis.
@ast
Are analogue insulins better t ...... n? Results of a meta-analysis.
@en
prefLabel
Are analogue insulins better t ...... n? Results of a meta-analysis.
@ast
Are analogue insulins better t ...... n? Results of a meta-analysis.
@en
P2093
P1433
P1476
Are analogue insulins better t ...... n? Results of a meta-analysis.
@en
P2093
P304
P356
10.1046/J.1464-5491.2003.01018.X
P577
2003-10-01T00:00:00Z